TO EVALUATE THE ANTIUROLITHIATIC ACTIVITY OF AQUEOUS EXTRACT OF CATHARANTHUS ROSEUS IN ETHYLENE-GLYCOL-INDUCED UROLITHIASIS IN RATS
DOI:
https://doi.org/10.22159/ijcpr.2024v16i5.5027Keywords:
Catharanthus roseus, Urolithiasis, Ethylene-glycol, Antiurolithiatic activity and herbal medicineAbstract
Objective: This study aimed to evaluate the potential antiurolithiatic activity of the aqueous extract of *Catharanthus roseus* in a rat model of ethylene-glycol-induced urolithiasis.
Methods: Thirty male Wistar rats were divided into five groups: Group I served as the control, Group II received ethylene glycol (0.75% v/v) in drinking water for the induction of urolithiasis, Group III received standard treatment (cystone), and Group IV was treated with the aqueous extract of Catharanthus roseus (200 mg/kg). Throughout the experimental period, various parameters such as urinary calcium, phosphate, oxalate levels, and kidney histopathology were assessed to evaluate the antiurolithiatic potential of Catharanthus roseus.
Results: The results demonstrated a significant reduction in urinary calculi formation, lowered calcium and oxalate excretion, and ameliorated histological changes in the kidneys of rats treated with the aqueous extract of Catharanthus roseus.
Conclusion: Our findings suggest that the aqueous extract of *Catharanthus roseus* possesses promising antiurolithiatic activity, potentially attributed to its ability to modulate urinary stone-forming parameters. Further studies are warranted to elucidate the underlying mechanisms and explore the therapeutic potential of *Catharanthus roseus* in managing urolithiasis.
Downloads
References
Thakore P, Liang TH. Urolithiasis. In: StatPearls; 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559101/ [Last accessed on 28 Aug 2024]
Alelign T, Petros B. Kidney stone disease: an update on current concepts. Adv Urol. 2018;2018:3068365. doi: 10.1155/2018/3068365, PMID 29515627.
Pharma D, Sadaphal N, Chitra Gupta D. An updated review on Catharanthus roseus: its traditional and modern use for humankind. Pharm Chem. 2022;14(8):48-54.
Alkaloid II. In vitro antidiabetic and antioxidant effects of different extracts of Catharanthus roseus and. Published online; 2020.
Ghosh S, Suryawanshi SA. Effect of Vinca rosea extracts in treatment of alloxan diabetes in male albino rats. Indian J Exp Biol. 2001;39(8):748-59. PMID 12018575.
Saxena N, Argal A. Study of antiurolithiatic activity of a formulated herbal suspension. Herba Pol. 2015;61(2):41-9. doi: 10.1515/hepo-2015-0014.
Tzou DT, Taguchi K, Chi T, Stoller ML. Animal models of urinary stone disease. Int J Surg. 2016;36(D):596-606. doi: 10.1016/j.ijsu.2016.11.018, PMID 27840313.
Rahman MU, Khan J, Jeyabalan G, Parveen G. Antiurolithiatic activity of curcumin against ethylene glycol-induced urolithiasis in male wistar rats. International Journal of Advances in Pharmacy Medicine and Bioallied Sciences. 2018;6(3):104-10.
Deemed BV. Antiurolithiatic activity of a polyherbal formulation against calcium oxalate induced urolithiasis in rats. J Adv Pharm Edu Res. 2013;3(1):31-41.
Sethiya NK, Brahmbhat K, Chauhan B, Mishra SH. Antiurolithiatic activity of Ensete superbum (Roxb.) Cheesman (wild banana) pseudostem on ethylene glycol induced urolithiasis in rats. Indian J Tradit Knowl. 2017;16(2):303-9.
Kaushik J, Tandon S, Bhardwaj R, Kaur T, Singla SK, Kumar J. Delving into the antiurolithiatic potential of tribulus terrestris extract through-in vivo efficacy and preclinical safety investigations in wistar rats. Sci Rep. 2019;9(1):15969. doi: 10.1038/s41598-019-52398-w, PMID 31685914.
Published
How to Cite
Issue
Section
Copyright (c) 2024 MEENAKSHI MALHOTRA, AJEET PAL SINGH
This work is licensed under a Creative Commons Attribution 4.0 International License.